Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aspen Aerogels (ASPN) Common Equity (2016 - 2025)

Historic Common Equity for Aspen Aerogels (ASPN) over the last 13 years, with Q3 2025 value amounting to $305.7 million.

  • Aspen Aerogels' Common Equity fell 3977.48% to $305.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $305.7 million, marking a year-over-year decrease of 3977.48%. This contributed to the annual value of $614.7 million for FY2024, which is 2594.99% up from last year.
  • Aspen Aerogels' Common Equity amounted to $305.7 million in Q3 2025, which was down 3977.48% from $308.8 million recorded in Q2 2025.
  • In the past 5 years, Aspen Aerogels' Common Equity ranged from a high of $614.7 million in Q4 2024 and a low of $66.6 million during Q1 2021
  • In the last 5 years, Aspen Aerogels' Common Equity had a median value of $314.8 million in 2025 and averaged $330.1 million.
  • Per our database at Business Quant, Aspen Aerogels' Common Equity surged by 24844.79% in 2022 and then plummeted by 4037.24% in 2025.
  • Aspen Aerogels' Common Equity (Quarter) stood at $128.4 million in 2021, then skyrocketed by 248.45% to $447.4 million in 2022, then rose by 9.08% to $488.1 million in 2023, then grew by 25.95% to $614.7 million in 2024, then plummeted by 50.26% to $305.7 million in 2025.
  • Its Common Equity was $305.7 million in Q3 2025, compared to $308.8 million in Q2 2025 and $314.8 million in Q1 2025.